Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Investor Presentaiton slide image

Investor Presentaiton

Historical revenue growth fueled by core Therapy Selection business 49% Total Revenue CAGR $91M $214M $287M $450M $374M INVESTOR 20 Therapy Selection growth drivers Reimbursement coverage Regulatory approvals Clinical data Commercial strength Biopharma partnerships Portfolio expansion DAY 23 2018 2019 2020 2021 2022 GUARDANT™ 142
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube